{"id":"https://openalex.org/W2008907277","doi":"https://doi.org/10.1016/j.hoc.2014.02.001","title":"Interferon, Interleukin-2, and Other Cytokines","display_name":"Interferon, Interleukin-2, and Other Cytokines","publication_year":2014,"publication_date":"2014-04-03","ids":{"openalex":"https://openalex.org/W2008907277","doi":"https://doi.org/10.1016/j.hoc.2014.02.001","mag":"2008907277","pmid":"https://pubmed.ncbi.nlm.nih.gov/24880948"},"language":"en","primary_location":{"id":"doi:10.1016/j.hoc.2014.02.001","doi":"https://doi.org/10.1016/j.hoc.2014.02.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.hoc.2014.02.001","pdf_url":null,"source":{"id":"https://openalex.org/S185414053","display_name":"Hematology/Oncology Clinics of North America","issn_l":"0889-8588","issn":["0889-8588","1558-1977"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology/Oncology Clinics of North America","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066489948","display_name":"Elizabeth Iannotti Buchbinder","orcid":"https://orcid.org/0000-0002-7979-8953","observed_orcids":["https://orcid.org/0000-0002-7979-8953","https://orcid.org/0000-0003-4626-1612"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Elizabeth I. Buchbinder","raw_affiliation_strings":["Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: ebuchbin@bidmc.harvard.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: ebuchbin@bidmc.harvard.edu","institution_ids":["https://openalex.org/I1316535847"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007052233","display_name":"David F. McDermott","orcid":"https://orcid.org/0000-0002-2675-5095","observed_orcids":["https://orcid.org/0000-0002-2675-5095","https://orcid.org/0000-0001-6978-0867"]},"institutions":[{"id":"https://openalex.org/I1316535847","display_name":"Beth Israel Deaconess Medical Center","ror":"https://ror.org/04drvxt59","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316535847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David F. McDermott","raw_affiliation_strings":["Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA","institution_ids":["https://openalex.org/I1316535847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5066489948"],"corresponding_institution_ids":["https://openalex.org/I1316535847"],"apc_list":{"value":3950,"currency":"USD","value_usd":3950},"apc_paid":null,"fwci":0.2635,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.25131996,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"28","issue":"3","first_page":"571","last_page":"583"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.9648000001907349,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.019700000062584877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.7519999742507935},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":1.0},{"id":"https://openalex.org/keywords/cytokine-therapy","display_name":"cytokine therapy","score":0.9350000023841858},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.8930000066757202},{"id":"https://openalex.org/keywords/patient-selection","display_name":"patient selection","score":0.8360000252723694},{"id":"https://openalex.org/keywords/toxicity-reduction","display_name":"toxicity reduction","score":0.8450000286102295},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8109999895095825}],"concepts":[{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.6329993605613708},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.5993584990501404},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.5366435050964355},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5124168992042542},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.4936310052871704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48756951093673706},{"id":"https://openalex.org/C116024289","wikidata":"https://www.wikidata.org/wiki/Q18039820","display_name":"Interleukin 20","level":5,"score":0.42164695262908936},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.28602004051208496},{"id":"https://openalex.org/C181901479","wikidata":"https://www.wikidata.org/wiki/Q14877650","display_name":"Interleukin 5","level":4,"score":0.18486696481704712}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.hoc.2014.02.001","doi":"https://doi.org/10.1016/j.hoc.2014.02.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.hoc.2014.02.001","pdf_url":null,"source":{"id":"https://openalex.org/S185414053","display_name":"Hematology/Oncology Clinics of North America","issn_l":"0889-8588","issn":["0889-8588","1558-1977"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology/Oncology Clinics of North America","raw_type":"journal-article"},{"id":"pmid:24880948","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24880948","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology/oncology clinics of North America","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":58,"referenced_works":["https://openalex.org/W197050217","https://openalex.org/W633168333","https://openalex.org/W1662416542","https://openalex.org/W1823669223","https://openalex.org/W1828940258","https://openalex.org/W1840790719","https://openalex.org/W1866549327","https://openalex.org/W1903239102","https://openalex.org/W1908752382","https://openalex.org/W1929485758","https://openalex.org/W1950572133","https://openalex.org/W1981218605","https://openalex.org/W1985981664","https://openalex.org/W1990435553","https://openalex.org/W1991148746","https://openalex.org/W1997825389","https://openalex.org/W2011493529","https://openalex.org/W2027567030","https://openalex.org/W2028552658","https://openalex.org/W2029275361","https://openalex.org/W2031188948","https://openalex.org/W2033856426","https://openalex.org/W2042031899","https://openalex.org/W2051636382","https://openalex.org/W2051962533","https://openalex.org/W2057908608","https://openalex.org/W2060926084","https://openalex.org/W2062359341","https://openalex.org/W2081171265","https://openalex.org/W2082742146","https://openalex.org/W2085237060","https://openalex.org/W2089401318","https://openalex.org/W2093345471","https://openalex.org/W2099289479","https://openalex.org/W2110092116","https://openalex.org/W2118449798","https://openalex.org/W2127734125","https://openalex.org/W2130537353","https://openalex.org/W2140330371","https://openalex.org/W2140793012","https://openalex.org/W2143381422","https://openalex.org/W2152385435","https://openalex.org/W2157207652","https://openalex.org/W2162425639","https://openalex.org/W2167016095","https://openalex.org/W2167925208","https://openalex.org/W2202787350","https://openalex.org/W2262045503","https://openalex.org/W2322553446","https://openalex.org/W2411989726","https://openalex.org/W2413986234","https://openalex.org/W2418246656","https://openalex.org/W2418805561","https://openalex.org/W2604033773","https://openalex.org/W4256189622","https://openalex.org/W6687915701","https://openalex.org/W6692543760","https://openalex.org/W6717188601"],"related_works":["https://openalex.org/W136285562","https://openalex.org/W2060826949","https://openalex.org/W1904332237","https://openalex.org/W2349008890","https://openalex.org/W2239332858","https://openalex.org/W2807864393","https://openalex.org/W2043578530","https://openalex.org/W4402301690","https://openalex.org/W2417215173","https://openalex.org/W2054138831"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}